stocksKOBO
KOBO

Kobo Biotech Ltd.

4.10-0.0 (-0.24%)
23 Oct, 12:00 AM

Annual Reports and Financial Documents

Kobo Biotech Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.
2013201420152016201720182019202020212022202320242025
Annual ReportsFY 2013FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Quarterly Results——————
Conference Calls—————————————
Presentations—————————————

Corporate Announcements and Regulatory Filings

Kobo Biotech Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.
  1. General24 Oct 2026
    The Hon'Ble NCLT Has Appointed Mr. Rajat Mukherjee As The Chairman Of The Monitoring Committee, In Place Of Ms. Namrata Amol Randeri, Resolution Professional, Who Had Tendered Her Resignation.
    Order of NCLT
  2. Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 201815 Oct 2026
    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
    Certificate under Reg. 74(5)of SEBI (DP)30.09.2026
  3. AGM24 Jul 2026
    Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
    outcome, summary proceddings and scrutinizer reprot of 32nd AGM for 31. 03.2025 on VC/OAVM
  4. AGM24 Jul 2026
    Shareholder Meeting / Postal Ballot-Outcome of AGM
    Proceedings of 32nd AGM for 31.03.2025 with reports and voting results.
  5. AGM24 Jul 2026
    Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
    Scrtnizer report for AGM held for 31.03.2024
  6. AGM24 Jul 2026
    Shareholder Meeting / Postal Ballot-Outcome of AGM
    Outcome of shareholder meeting held thorugh VC/OAVM for 31.03.2024
  7. Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 201817 Jul 2026
    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
    Certificate under regulation 74(5) of SEBI (DP) Regulations, Quarter 30.06.2026
  8. General16 Jul 2026
    Update On Implementation Of Approved Resolution Plan Pursuant To
    Update on Implementation of Approved Resolution Plan
  9. Reg. 34 (1) Annual Report29 Jun 2026
    Reg. 34 (1) Annual Report.
    Reg. 34 (1) Annual Report. for 31.03.2025
  10. Reg. 34 (1) Annual Report29 Jun 2026
    Reg. 34 (1) Annual Report.
    Annual Report for the Financial Year 2023-24
  11. AGM26 Jun 2026
    32St Annual General Meeting Of The Members Will Be Held On Friday, July 24, 2026 At 11.00 A.M. (IST), Through Video
    Notice and Annual Report for 2025
  12. AGM26 Jun 2026
    31St Annual General Meeting Of The Memberswill Be Held On Friday, July 24, 2026 At 10.00 A.M. (IST), Through Video
    Notice and Annual Report 2023-24 for 31st AGM of the company will be held on 24.07.2026 at 10.00 a.m. throught VC/OAVM
  13. Closure of Trading Window24 Jun 2026
    Closure of Trading Window
    intimation of closure of trading window
  14. Approval of Resolution plan by Tribunal13 May 2026
    Corporate Insolvency Resolution Process (CIRP)-Approval of Resolution plan by Tribunal
    Spacific features and deatils pf the resolution Plan as apprpved by the NCLT
  15. Approval of Resolution plan by Tribunal11 May 2026
    Corporate Insolvency Resolution Process (CIRP)-Approval of Resolution plan by Tribunal
    Approval of Resolution Plan and receipt of Order from NCLT
  16. Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 201815 Apr 2026
    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
    Compliance certificate under Reg. 74(5) of SEBI (DP) for the quarter ended 31.03.2026
  17. General15 Apr 2026
    Intimation Regarding Non-Applicability Of Large Entity Disclosure
    Intimation Regarding Non Applicability of Large Entity Disclosure
  18. Closure of Trading Window30 Mar 2026
    Closure of Trading Window
    Intimatioin for Closure of Trading Window for Financial Resilt for March 31,2026
  19. Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 201811 Feb 2026
    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
    Submission of certificate under Reg. 74(5) of SEBI (DP) 30.06.2024
  20. Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 201811 Feb 2026
    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
    Submission of certificate under Reg. 74(5) of SEBI (DP) 30.09.2024

Frequently Asked Questions

Where can I download the annual report of Kobo Biotech Ltd.?
Annual reports of Kobo Biotech Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.
Where can I find the quarterly results of Kobo Biotech Ltd.?
Quarterly earnings results and presentations of Kobo Biotech Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.
Does Kobo Biotech Ltd. publish earnings call transcripts?
Earnings call transcripts of Kobo Biotech Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.
Where can I find investor presentations of Kobo Biotech Ltd.?
Investor presentations and annual day presentations of Kobo Biotech Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.
What are the recent corporate announcements of Kobo Biotech Ltd.?
Corporate announcements and regulatory filings of Kobo Biotech Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.
How do I access the regulatory filings of Kobo Biotech Ltd.?
Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Kobo Biotech Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.
What is the ISIN of Kobo Biotech Ltd.?
The ISIN (International Securities Identification Number) of Kobo Biotech Ltd. is INE881A01015. This is the unique identifier used across exchanges and depositories.
On which stock exchange is Kobo Biotech Ltd. listed?
Kobo Biotech Ltd. is listed on NSE and BSE. The NSE symbol is KOBO and the BSE code is -.
Where can I find the shareholding pattern of Kobo Biotech Ltd.?
The quarterly shareholding pattern of Kobo Biotech Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.
How current is the data for Kobo Biotech Ltd. on Sharpely?
Share price data for Kobo Biotech Ltd. is updated as of 23 Oct 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.